Soluble Biotech Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
4
- Latest Deal Type
-
M&A
Soluble Biotech General Information
Description
Developer of formulations intended to promote solubility and stability of protein based formulations. The company's technology can be used to formulate proteins including antibodies, enzymes, cell surface proteins, membrane bound proteins and signaling proteins, enabling pharmaceutical and biotechnology industries to get optimized formulations at significant costs.
Contact Information
Website
www.solublebiotech.comCorporate Office
- 200 Riverhills Business Park
- Suite 250
- Birmingham, AL 35242
- United States
Corporate Office
- 200 Riverhills Business Park
- Suite 250
- Birmingham, AL 35242
- United States
Soluble Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 27-May-2020 | Completed | Generating Revenue | |||
| 6. Merger/Acquisition | 01-Nov-2016 | Completed | Generating Revenue | |||
| 5. Grant | 20-Apr-2015 | Completed | Startup | |||
| 4. Early Stage VC (Series B) | 17-Dec-2013 | Completed | Startup | |||
| 3. Grant | 01-Jun-2012 | Completed | Startup | |||
| 2. Accelerator/Incubator | $1M | Completed | Startup | |||
| 1. Early Stage VC (Series A) | 11-Jul-2011 | $1M | $1M | Completed | Startup |
Soluble Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Soluble Biotech Comparisons
Industry
Financing
Details
Soluble Biotech Competitors (12)
One of Soluble Biotech’s 12 competitors is Cell Signaling Technology, a Corporation company based in Danvers, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cell Signaling Technology | Corporation | Danvers, MA | ||||
| PeproTech | Corporate Backed or Acquired | Cranbury, NJ | ||||
| BioCryst Pharmaceuticals | Corporation | Durham, NC | ||||
| Light Chain Bioscience | Formerly PE-Backed | Geneva, Switzerland | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA |
Soluble Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Soluble Biotech Patents
Soluble Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20130330759-A1 | Enhancing endotoxin detection | Active | 28-Feb-2011 | ||
| US-8921063-B2 | Enhancing endotoxin detection | Inactive | 28-Feb-2011 | ||
| US-20100041061-A1 | Detecting gram negative bacteria or lipopolysaccharide via inactive acidic protease binding | Active | 18-Aug-2008 | ||
| US-7846678-B2 | Detecting gram negative bacteria or lipopolysaccharide via inactive acidic protease binding | Inactive | 18-Aug-2008 | ||
| US-20110020854-A1 | Enhancing endotoxin detection | Active | 18-Aug-2008 | G01N33/56911 |
Soluble Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Soluble Biotech Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Greer Capital Advisors | Venture Capital | Minority | ||
| Innovation Depot | Accelerator/Incubator | |||
| Inventa Biotech | Corporation | Majority | ||
| National Institute of General Medical Sciences | Government | |||
| Targeted Technology | Venture Capital | Minority |
Soluble Biotech Acquisitions (1)
Soluble Biotech’s most recent deal was a Merger/Acquisition with Dilyx Biotechnologies. The deal was made on 02-Oct-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dilyx Biotechnologies | 02-Oct-2014 | Merger/Acquisition | Laboratory Services (Healthcare) |
Soluble Biotech FAQs
-
When was Soluble Biotech founded?
Soluble Biotech was founded in 2008.
-
Where is Soluble Biotech headquartered?
Soluble Biotech is headquartered in Birmingham, AL.
-
What is the size of Soluble Biotech?
Soluble Biotech has 4 total employees.
-
What industry is Soluble Biotech in?
Soluble Biotech’s primary industry is Drug Discovery.
-
Is Soluble Biotech a private or public company?
Soluble Biotech is a Private company.
-
What is Soluble Biotech’s current revenue?
The current revenue for Soluble Biotech is .
-
How much funding has Soluble Biotech raised over time?
Soluble Biotech has raised $1.75M.
-
Who are Soluble Biotech’s investors?
Greer Capital Advisors, Innovation Depot, Inventa Biotech, National Institute of General Medical Sciences, and Targeted Technology have invested in Soluble Biotech.
-
Who are Soluble Biotech’s competitors?
Cell Signaling Technology, PeproTech, BioCryst Pharmaceuticals, Light Chain Bioscience, and Inovio Pharmaceuticals are some of the 12 competitors of Soluble Biotech.
-
When was Soluble Biotech acquired?
Soluble Biotech was acquired on 27-May-2020.
-
Who acquired Soluble Biotech?
Soluble Biotech was acquired by Axe Compute.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
